Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-11-22

AUTHORS

Atsuko Kishi, Yasushi Takamori, Kazuyuki Ogawa, Shoichi Takano, Shuji Tomita, Mari Tanigawa, Makiko Niman, Tsunataro Kishida, Setsuya Fujita

ABSTRACT

. Granulysin has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells. The aim of the present study was to elucidate whether intracellular expression of granulysin and perforin by NK cells might be associated with progression of cancer. Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3– CD16+ cells in healthy controls. In contrast, cancer patients exhibited significantly decreased levels of granulysin expression (P<0.005), despite having equally high levels of perforin expression in comparison with healthy controls. The tumor-free patients expressed granulysin at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of granulysin compared to healthy controls (P<0.0001). Similarly, patients with an advanced performance status had significantly fewer granulysin-positive NK cells than healthy controls. Meanwhile, a considerable number of the tumor-bearing patients showed a decrease in the number of circulating NK cells, and a correlation between impaired granulysin expression and reduced circulating NK cells was observed. These findings suggest that the tumor-bearing patients with impaired granulysin expression were in an immunosuppressive state. In conclusion, impaired expression of granulysin by NK cells correlates with progression of cancer, and determination of granulysin expression might prove informative for assessing the immunological condition of cancer patients. More... »

PAGES

604-614

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002620100228

DOI

http://dx.doi.org/10.1007/s002620100228

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037020774

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11807624


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Differentiation, T-Lymphocyte", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppression Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Perforin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pore Forming Cytotoxic Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan", 
          "id": "http://www.grid.ac/institutes/grid.452539.c", 
          "name": [
            "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kishi", 
        "givenName": "Atsuko", 
        "id": "sg:person.01215344364.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215344364.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takamori", 
        "givenName": "Yasushi", 
        "id": "sg:person.01070121742.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070121742.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ogawa", 
        "givenName": "Kazuyuki", 
        "id": "sg:person.01022006542.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022006542.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takano", 
        "givenName": "Shoichi", 
        "id": "sg:person.01316425345.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316425345.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan", 
          "id": "http://www.grid.ac/institutes/grid.452539.c", 
          "name": [
            "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomita", 
        "givenName": "Shuji", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan", 
          "id": "http://www.grid.ac/institutes/grid.452539.c", 
          "name": [
            "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanigawa", 
        "givenName": "Mari", 
        "id": "sg:person.01265633665.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265633665.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan", 
          "id": "http://www.grid.ac/institutes/grid.452539.c", 
          "name": [
            "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niman", 
        "givenName": "Makiko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan", 
          "id": "http://www.grid.ac/institutes/grid.452539.c", 
          "name": [
            "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kishida", 
        "givenName": "Tsunataro", 
        "id": "sg:person.01357032643.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357032643.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan", 
          "id": "http://www.grid.ac/institutes/grid.452539.c", 
          "name": [
            "Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujita", 
        "givenName": "Setsuya", 
        "id": "sg:person.013164252512.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013164252512.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf03258491", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029662046", 
          "https://doi.org/10.1007/bf03258491"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-79414-8_1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003964845", 
          "https://doi.org/10.1007/978-3-642-79414-8_1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/370650a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018360617", 
          "https://doi.org/10.1038/370650a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002620050586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017204190", 
          "https://doi.org/10.1007/s002620050586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-68069-4_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015587817", 
          "https://doi.org/10.1007/978-3-642-68069-4_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/369031a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040303183", 
          "https://doi.org/10.1038/369031a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-11-22", 
    "datePublishedReg": "2001-11-22", 
    "description": "Abstract. Granulysin has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells. The aim of the present study was to elucidate whether intracellular expression of granulysin and perforin by NK cells might be associated with progression of cancer. Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3\u2013 CD16+ cells in healthy controls. In contrast, cancer patients exhibited significantly decreased levels of granulysin expression (P<0.005), despite having equally high levels of perforin expression in comparison with healthy controls. The tumor-free patients expressed granulysin at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of granulysin compared to healthy controls (P<0.0001). Similarly, patients with an advanced performance status had significantly fewer granulysin-positive NK cells than healthy controls. Meanwhile, a considerable number of the tumor-bearing patients showed a decrease in the number of circulating NK cells, and a correlation between impaired granulysin expression and reduced circulating NK cells was observed. These findings suggest that the tumor-bearing patients with impaired granulysin expression were in an immunosuppressive state. In conclusion, impaired expression of granulysin by NK cells correlates with progression of cancer, and determination of granulysin expression might prove informative for assessing the immunological condition of cancer patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002620100228", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "50"
      }
    ], 
    "keywords": [
      "tumor-bearing patients", 
      "NK cells", 
      "granulysin expression", 
      "healthy controls", 
      "progression of cancer", 
      "cancer patients", 
      "advanced performance status", 
      "natural killer cells", 
      "tumor-free patients", 
      "cytotoxic T lymphocytes", 
      "presence of perforin", 
      "CD3-CD16", 
      "performance status", 
      "killer cells", 
      "perforin expression", 
      "immunosuppressive state", 
      "T lymphocytes", 
      "immunological conditions", 
      "cytotoxic granules", 
      "patients", 
      "perforin", 
      "granulysin", 
      "impaired expression", 
      "cytometric analysis", 
      "tumor cells", 
      "intracellular pathogens", 
      "intracellular expression", 
      "cancer", 
      "infected cells", 
      "cytotoxic effects", 
      "progression", 
      "high levels", 
      "effector molecules", 
      "present study", 
      "cells", 
      "differential expression", 
      "expression", 
      "low levels", 
      "levels", 
      "lymphocytes", 
      "control", 
      "considerable number", 
      "conclusion", 
      "correlation", 
      "status", 
      "pathogens", 
      "aim", 
      "findings", 
      "decrease", 
      "granules", 
      "study", 
      "number", 
      "contrast", 
      "effect", 
      "presence", 
      "comparison", 
      "analysis", 
      "molecules", 
      "conditions", 
      "determination", 
      "state"
    ], 
    "name": "Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer", 
    "pagination": "604-614", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037020774"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002620100228"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11807624"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002620100228", 
      "https://app.dimensions.ai/details/publication/pub.1037020774"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_339.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002620100228"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002620100228'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002620100228'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002620100228'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002620100228'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      108 URIs      94 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002620100228 schema:about N0c4c1ece538945b0a8db526718c8c2a5
2 N22860aaf530f491e904a0726abde31e7
3 N27729d2e62d74d68b1ff692f3b41ee17
4 N33c8d1a68ca8417abc00c414954c2288
5 N3abc091849194ed78b3f3cbd1d8a3ada
6 N3db034da693e49c584ce5101bf0961db
7 N59bfe11272b74f9cb3ea31801151e786
8 N68869a0120af4fe28238be6cb2455340
9 N6b10f8d66bd94aab96da46f38d548c16
10 N96fdef11b32e4856a89f648a806fb337
11 Ncb359392f7294f22aa05318748b3c398
12 Ncf83a7ce14bd4516adb9b9e29d1a555c
13 Ndc61e6648b4d4601a33e8ceac836a67b
14 Ne29d5cc4c2c44665a02b3b176920af15
15 Nf9fe108331904328b335eae1c802fa35
16 Nfa7bfd5ed2d3450f9d87e1c43a26006b
17 anzsrc-for:11
18 anzsrc-for:1107
19 schema:author N193978dadd1d4bee919d738d683e64cc
20 schema:citation sg:pub.10.1007/978-3-642-68069-4_7
21 sg:pub.10.1007/978-3-642-79414-8_1
22 sg:pub.10.1007/bf03258491
23 sg:pub.10.1007/s002620050586
24 sg:pub.10.1038/369031a0
25 sg:pub.10.1038/370650a0
26 schema:datePublished 2001-11-22
27 schema:datePublishedReg 2001-11-22
28 schema:description Abstract. Granulysin has been identified as an effector molecule co-localized with perforin in the cytotoxic granules of cytotoxic T lymphocytes and natural killer (NK) cells, and has been reported to kill intracellular pathogens in infected cells in the presence of perforin and to induce a cytotoxic effect against tumor cells. The aim of the present study was to elucidate whether intracellular expression of granulysin and perforin by NK cells might be associated with progression of cancer. Flow cytometric analysis demonstrated high levels of perforin and granulysin expression by CD3– CD16+ cells in healthy controls. In contrast, cancer patients exhibited significantly decreased levels of granulysin expression (P<0.005), despite having equally high levels of perforin expression in comparison with healthy controls. The tumor-free patients expressed granulysin at levels similar to healthy controls, while the progressive tumor-bearing patients expressed remarkably lower levels of granulysin compared to healthy controls (P<0.0001). Similarly, patients with an advanced performance status had significantly fewer granulysin-positive NK cells than healthy controls. Meanwhile, a considerable number of the tumor-bearing patients showed a decrease in the number of circulating NK cells, and a correlation between impaired granulysin expression and reduced circulating NK cells was observed. These findings suggest that the tumor-bearing patients with impaired granulysin expression were in an immunosuppressive state. In conclusion, impaired expression of granulysin by NK cells correlates with progression of cancer, and determination of granulysin expression might prove informative for assessing the immunological condition of cancer patients.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N480a2b634f8d49d697a255e88e00e7a3
32 Nccae4bdb549f4a2da67633c1e231be0a
33 sg:journal.1096240
34 schema:keywords CD3-CD16
35 NK cells
36 T lymphocytes
37 advanced performance status
38 aim
39 analysis
40 cancer
41 cancer patients
42 cells
43 comparison
44 conclusion
45 conditions
46 considerable number
47 contrast
48 control
49 correlation
50 cytometric analysis
51 cytotoxic T lymphocytes
52 cytotoxic effects
53 cytotoxic granules
54 decrease
55 determination
56 differential expression
57 effect
58 effector molecules
59 expression
60 findings
61 granules
62 granulysin
63 granulysin expression
64 healthy controls
65 high levels
66 immunological conditions
67 immunosuppressive state
68 impaired expression
69 infected cells
70 intracellular expression
71 intracellular pathogens
72 killer cells
73 levels
74 low levels
75 lymphocytes
76 molecules
77 natural killer cells
78 number
79 pathogens
80 patients
81 perforin
82 perforin expression
83 performance status
84 presence
85 presence of perforin
86 present study
87 progression
88 progression of cancer
89 state
90 status
91 study
92 tumor cells
93 tumor-bearing patients
94 tumor-free patients
95 schema:name Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer
96 schema:pagination 604-614
97 schema:productId N2f71df4d1c934e67888901f36570c291
98 N333093ee2e354442ae853246cd752dcf
99 N642c999b056b424988769b4232c4843c
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037020774
101 https://doi.org/10.1007/s002620100228
102 schema:sdDatePublished 2022-09-02T15:49
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher Ne5ed3916dc734a33bd851eb1a59c3e4e
105 schema:url https://doi.org/10.1007/s002620100228
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N0c4c1ece538945b0a8db526718c8c2a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Humans
111 rdf:type schema:DefinedTerm
112 N193978dadd1d4bee919d738d683e64cc rdf:first sg:person.01215344364.67
113 rdf:rest N7e0d34492b0b43069500db18e53327af
114 N22860aaf530f491e904a0726abde31e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Immunosuppression Therapy
116 rdf:type schema:DefinedTerm
117 N27729d2e62d74d68b1ff692f3b41ee17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Flow Cytometry
119 rdf:type schema:DefinedTerm
120 N29cb0195c8324086aa713f31d39a6c75 schema:affiliation grid-institutes:grid.452539.c
121 schema:familyName Tomita
122 schema:givenName Shuji
123 rdf:type schema:Person
124 N2f71df4d1c934e67888901f36570c291 schema:name doi
125 schema:value 10.1007/s002620100228
126 rdf:type schema:PropertyValue
127 N333093ee2e354442ae853246cd752dcf schema:name pubmed_id
128 schema:value 11807624
129 rdf:type schema:PropertyValue
130 N33c8d1a68ca8417abc00c414954c2288 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Neoplasms
132 rdf:type schema:DefinedTerm
133 N3abc091849194ed78b3f3cbd1d8a3ada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Pore Forming Cytotoxic Proteins
135 rdf:type schema:DefinedTerm
136 N3db034da693e49c584ce5101bf0961db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Prognosis
138 rdf:type schema:DefinedTerm
139 N40fef87c0e5b40e39aa3712ecaad7400 rdf:first sg:person.01357032643.67
140 rdf:rest Nbe25d01ecce84d4cbfd5006edeed2b70
141 N480a2b634f8d49d697a255e88e00e7a3 schema:issueNumber 11
142 rdf:type schema:PublicationIssue
143 N59bfe11272b74f9cb3ea31801151e786 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Biomarkers, Tumor
145 rdf:type schema:DefinedTerm
146 N642c999b056b424988769b4232c4843c schema:name dimensions_id
147 schema:value pub.1037020774
148 rdf:type schema:PropertyValue
149 N68869a0120af4fe28238be6cb2455340 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Female
151 rdf:type schema:DefinedTerm
152 N6b10f8d66bd94aab96da46f38d548c16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Perforin
154 rdf:type schema:DefinedTerm
155 N7e0d34492b0b43069500db18e53327af rdf:first sg:person.01070121742.32
156 rdf:rest N9de9bc7001224e9483bfa38d8067fc63
157 N96fdef11b32e4856a89f648a806fb337 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Aged
159 rdf:type schema:DefinedTerm
160 N9de9bc7001224e9483bfa38d8067fc63 rdf:first sg:person.01022006542.43
161 rdf:rest Ncac2aa1130ce4828b9d18f132b991dc1
162 N9f00e3bf1040491ebae8e8aeb9e86469 rdf:first sg:person.01265633665.27
163 rdf:rest Nb5017124c12e4ebebc8f1e07348d47b3
164 Nac8c02e9835a40a8b34b02277124a473 rdf:first N29cb0195c8324086aa713f31d39a6c75
165 rdf:rest N9f00e3bf1040491ebae8e8aeb9e86469
166 Nb5017124c12e4ebebc8f1e07348d47b3 rdf:first Nc16cb8faa7744f879d028b7d2f217e78
167 rdf:rest N40fef87c0e5b40e39aa3712ecaad7400
168 Nbe25d01ecce84d4cbfd5006edeed2b70 rdf:first sg:person.013164252512.14
169 rdf:rest rdf:nil
170 Nc16cb8faa7744f879d028b7d2f217e78 schema:affiliation grid-institutes:grid.452539.c
171 schema:familyName Niman
172 schema:givenName Makiko
173 rdf:type schema:Person
174 Ncac2aa1130ce4828b9d18f132b991dc1 rdf:first sg:person.01316425345.29
175 rdf:rest Nac8c02e9835a40a8b34b02277124a473
176 Ncb359392f7294f22aa05318748b3c398 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Membrane Glycoproteins
178 rdf:type schema:DefinedTerm
179 Nccae4bdb549f4a2da67633c1e231be0a schema:volumeNumber 50
180 rdf:type schema:PublicationVolume
181 Ncf83a7ce14bd4516adb9b9e29d1a555c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Antigens, Differentiation, T-Lymphocyte
183 rdf:type schema:DefinedTerm
184 Ndc61e6648b4d4601a33e8ceac836a67b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Killer Cells, Natural
186 rdf:type schema:DefinedTerm
187 Ne29d5cc4c2c44665a02b3b176920af15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Middle Aged
189 rdf:type schema:DefinedTerm
190 Ne5ed3916dc734a33bd851eb1a59c3e4e schema:name Springer Nature - SN SciGraph project
191 rdf:type schema:Organization
192 Nf9fe108331904328b335eae1c802fa35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Male
194 rdf:type schema:DefinedTerm
195 Nfa7bfd5ed2d3450f9d87e1c43a26006b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Adult
197 rdf:type schema:DefinedTerm
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
202 schema:name Immunology
203 rdf:type schema:DefinedTerm
204 sg:journal.1096240 schema:issn 0340-7004
205 1432-0851
206 schema:name Cancer Immunology, Immunotherapy
207 schema:publisher Springer Nature
208 rdf:type schema:Periodical
209 sg:person.01022006542.43 schema:affiliation grid-institutes:None
210 schema:familyName Ogawa
211 schema:givenName Kazuyuki
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022006542.43
213 rdf:type schema:Person
214 sg:person.01070121742.32 schema:affiliation grid-institutes:None
215 schema:familyName Takamori
216 schema:givenName Yasushi
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070121742.32
218 rdf:type schema:Person
219 sg:person.01215344364.67 schema:affiliation grid-institutes:grid.452539.c
220 schema:familyName Kishi
221 schema:givenName Atsuko
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215344364.67
223 rdf:type schema:Person
224 sg:person.01265633665.27 schema:affiliation grid-institutes:grid.452539.c
225 schema:familyName Tanigawa
226 schema:givenName Mari
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265633665.27
228 rdf:type schema:Person
229 sg:person.013164252512.14 schema:affiliation grid-institutes:grid.452539.c
230 schema:familyName Fujita
231 schema:givenName Setsuya
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013164252512.14
233 rdf:type schema:Person
234 sg:person.01316425345.29 schema:affiliation grid-institutes:None
235 schema:familyName Takano
236 schema:givenName Shoichi
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316425345.29
238 rdf:type schema:Person
239 sg:person.01357032643.67 schema:affiliation grid-institutes:grid.452539.c
240 schema:familyName Kishida
241 schema:givenName Tsunataro
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357032643.67
243 rdf:type schema:Person
244 sg:pub.10.1007/978-3-642-68069-4_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015587817
245 https://doi.org/10.1007/978-3-642-68069-4_7
246 rdf:type schema:CreativeWork
247 sg:pub.10.1007/978-3-642-79414-8_1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003964845
248 https://doi.org/10.1007/978-3-642-79414-8_1
249 rdf:type schema:CreativeWork
250 sg:pub.10.1007/bf03258491 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029662046
251 https://doi.org/10.1007/bf03258491
252 rdf:type schema:CreativeWork
253 sg:pub.10.1007/s002620050586 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017204190
254 https://doi.org/10.1007/s002620050586
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/369031a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040303183
257 https://doi.org/10.1038/369031a0
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/370650a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018360617
260 https://doi.org/10.1038/370650a0
261 rdf:type schema:CreativeWork
262 grid-institutes:None schema:alternateName B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan
263 schema:name B.M.L. R&D Center, 1361-1, Matoba, Kawagoe, Saitama, 350-11, Japan
264 rdf:type schema:Organization
265 grid-institutes:grid.452539.c schema:alternateName Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan
266 schema:name Louis Pasteur Center for Medical Research, 103-5, Tanaka Monzen-cho, Sakyo-ku, Kyoto, 606-8225, Japan
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...